Takeda Pharmaceutical Co Ltd

Moderna Inc said on Wednesday its Japanese distribution partner, Takeda Pharmaceutical Co Ltd, planned to initiate the recall of three lots of its COVID-19 vaccine that were suspended due to contamination.

Takeda Pharmaceutical Co Ltd lost its bid at the 2nd U.S. Circuit Court of Appeals on Wednesday to escape claims that it misdescribed its patents to the U.S. Food and Drug Administration to improperly delay generic versions of its blockbuster diabetes drug Actos.

Takeda Pharmaceutical Co has agreed to pay $1.85 million to settle claims by consumers that its predecessor Shire PLC delayed the launch of a generic version of its ADHD drug Intuniv through an illegal settlement with generic drugmaker Actavis.

Takeda Pharmaceutical Co said on Monday it will record a provision of about 63 billion yen ($574.56 million) in its financial statements for the first quarter to reflect a decision by Ireland's tax appeals body relating to tax assessment received by company's unit on a break...

Takeda Pharmaceutical Co said on Tuesday it agreed to supply an additional 50 million doses of Moderna Inc's COVID-19 vaccine to Japan.

Takeda Pharmaceutical Co on Tuesday said it may double imports of Moderna Inc's COVID-19 vaccine to help Japan speed up COVID-19 inoculation efforts that have trailed most wealthy countries.

Japanese drugmaker Takeda Pharmaceutical Co, which is importing Moderna Inc 's COVID-19 vaccine into Japan, said interim results of clinical trials ahead of domestic regulatory approvals have been positive.

Novavax Inc said on Friday the distribution of its COVID-19 vaccine in Japan is expected to begin in late 2021 or early 2022 and continue for the near-term, predicting the need for protection against variants in the future.

Japanese regulators are set to approve Moderna Inc's COVID-19 vaccine as soon as May 21, the Yomiuri Shimbun newspaper reported Saturday, without citing the source of the information.

Japan's Takeda Pharmaceutical Co said on Thursday it had started regulatory submissions to Europe's health regulator for its dengue vaccine candidate, which is being developed for individuals aged four to 60.

Germany's IDT Biologica said on Monday it would make Johnson & Johnson's COVID-19 vaccine using capacity previously reserved by Japan's Takeda, helping to ease concerns about the U.S. drugmaker's ability to meet its production goals.

Japan's Takeda Pharmaceutical Co Ltd said on Monday it had signed an agreement with contract manufacturer IDT Biologika GmbH to manufacture Johnson & Johnson's single-dose COVID-19 vaccine. (Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)

Takeda Pharmaceutical said it had asked regulators to approve use of Moderna's COVID-19 vaccine on Friday, which would add a third option to Japan's vaccination programme.

Japan's regulators were asked on Friday to approve use of the COVID-19 vaccine of Moderna Inc , the third such vaccine in the nation that began its inoculation effort last month.

Takeda Pharmaceutical Co will spend as much as $856 million to secure global rights from Ovid Therapeutics Inc to an experimental drug being developed to treat rare epilepsy, the companies said on Wednesday.

A federal appeals court has upheld a $182 million judgment in favor of Bayer in a patent infringement lawsuit targeting Takeda Pharmaceutical Co unit Baxalta Inc's hemophilia drug Adynovate.

Takeda Pharmaceutical Co said on Friday it agreed to sell four diabetes products in Japan to Teijin Pharma Ltd for 133 billion yen ($1.25 billion).

Takeda Pharmaceutical Co said on Wednesday the first patient had been given Novavax Inc's COVID-19 vaccine candidate in a Japanese clinical trial.

A federal appeals court has upheld Takeda Pharmaceutical Co Ltd's patent on the active ingredient in its Type II diabetes drugs Nesina, Oseni and Kazano, rejecting challenges by generic drugmakers that had hoped to make their own versions of the drugs.